The aim of this study was to explore the serum levels of sICAM-1 and galectin-3 in patients with type 2 diabetes mellitus and COVID-19 and compare them with those in healthy individuals to provide insight into the inflammatory processes associated with this comorbidity. This evidence concerns the gene LGALS3 and type 2 diabetes mellitus.